Atlas Trials

Study to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver Disease

Clinical trial NCT06272630 · COMPLETED

Trial details

NCT number
NCT06272630
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Liver Disease
Start date
2023-02-06
Primary completion
2024-03-29
Enrollment
263

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.